China-based Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with US-based...
Sankara Eye Hospital, India and The Chinese University of Hong Kong (CUHK) recently signed a landmark Memorandum of...
SystImmune and parent company Sichuan Biokin Pharmaceutical have received regulatory approval in China for iza-bren, als...
China-based CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that as...
Chime Biologics, a global biologics contract development and manufacturing organisation (CDMO), has announced the inaugu...
Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO) for biotechs, today announced ...
WuXi Biologics’ Suzhou Biosafety Testing Center has passed a European Medicines Agency Good Manufacturing Practice...
Germany-based ZEISS Medical Technology held a signing ceremony with the Aier Eye Hospital Group, China, entering into a ...
A research team led by Hong Kong Baptist University (HKBU) has discovered that extracts from the Justicia Chin...
Inflammatory bowel disease is becoming a growing focus within immunology innovation across Asia-Pacific, as the region s...
A research team from The Hong Kong University of Science and Technology (HKUST), together with an HKUST-incubated m...
China-based Simcere Pharmaceutical Group has entered into a research collaboration agreement with Stanford Medicine, US ...
China-based QingSong Health Corp and Basel Medical Group have announced the signing of a Memorandum of Strateg...
China-based Everest Medicines has entered into an exclusive licensing agreement with Jiangsu Vcare PharmaTech Co., ...
LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and ...
Australia-based Gelteq has announced the establishment of a new Gelteq Centre of Excellence in Guangdong Province, China...
Shanghai Henlius Biotech and Organon have received European Commission marketing authorisation for POHERDY, a pertuzumab...
China-based Everest Medicines has entered into an exclusive licensing and collaboration agreement with US-based Travere ...
China-based Haisco Pharmaceutical Group has announced a licensing and research collaboration with American firm Eli Lill...
Biond Biologics, a private clinical-stage biotechnology company developing first-in-class immunotherapies for cance...
China-based Innovent Biologics and American firm Pfizer Inc. have entered into a strategic global licensing and collabor...
Samsung Epis Holdings Co., an investment holding company dedicated to innovation in biopharmaceuticals and biotechnology...
Insilico Medicine, a Hong Kong-headquartered clinical-stage generative artificial intelligence (AI)-driven biotechnology...
Cornerstone Robotics (CSR), a leading global innovator in surgical robotics based in Hong Kong, China, has announced tha...
On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementat...
